What does TREATEX do?

TREATEX is registered with the CBE as active in: Vervaardiging van kunststoffen in primaire vormen. Public Limited, started on 15 June 1989, 2 establishments.

What is the address of TREATEX?

The registered office of TREATEX is located at Vaartstraat 34, 3600 Genk.

Is TREATEX still active?

Yes. According to the CBE (29 October 2026) TREATEX is active, legal situation “Normale toestand”, started on 15 June 1989.

Is TREATEX registered on Peppol?

Yes, TREATEX is registered on the Peppol network with ID 0208:0437745657.

What is the enterprise number of TREATEX?

The enterprise number of TREATEX is BE0437745657.

When was TREATEX founded?

TREATEX was founded on 15 June 1989.

Who are the directors of TREATEX?

According to the 2025 annual accounts, the directors of TREATEX are: TODEX BV, Dennis De Maeyer.

Is TREATEX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 15 June 1989; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did TREATEX make in 2025?

TREATEX posted a profit after taxes of € 3,127,765 in financial year 2025.

What is the revenue of TREATEX?

As a small company, TREATEX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 4,982,094.

How much does an employee at TREATEX earn?

The average wage cost per full-time employee at TREATEX was € 37,800 in 2025: staff costs of € 321,663 for 8.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does TREATEX have?

According to the 2025 annual accounts, TREATEX has 8.5 full-time equivalents (FTE).

TREATEX (Public Limited) - Genk - BE0437745657

Dossier TREATEX, printed on 29 October 2026 from databakkes.be/en/0437745657/treatex. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

TREATEX from Genk, company number BE0437745657, closed financial year 2025 with a result of € 3.1 million after tax. For that financial year TREATEX recorded a gross margin of € 5 million and equity of € 6.9 million. Compared with financial year 2024, the result moved from € 4,882 to € 3.1 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 8, 2026.

What it is worth Growing

€ 6.9 million

▲ 82% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 3.1 million

▲ € 3.1 million vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 543,138

▲ € 481,530 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 5.5 million.

People and assets in 2025

Full-time equivalents

8.5

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 321,663

▼ 5% vs 2024

€ 37,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 103,274

▼ 14% vs 2024

Of which on lease € 61,541.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 2.7 million

▼ 28% vs 2024

€ 526,910 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 321,297

▼ 29% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 36,216

▼ 42% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 2,122,788 Gross margin 2022: € 2,122,788 First fiscal year in the series	€ 770,854 Gross margin 2023: € 770,854 ▼ 64% vs 2022 (€ 2,122,788) Unfavourable step	€ 1,033,220 Gross margin 2024: € 1,033,220 ▲ 34% vs 2023 (€ 770,854) Favourable step	€ 4,982,094 Gross margin 2025: € 4,982,094 ▲ € 3.9 million vs 2024 (€ 1,033,220) Favourable step	▲ € 3.9 million
Profit after taxes	€ 1,011,457 Profit after taxes 2022: € 1,011,457 First fiscal year in the series	€ -10,945 Profit after taxes 2023: € -10,945 ▼ € 1 million vs 2022 (€ 1,011,457) Unfavourable step	€ 4,882 Profit after taxes 2024: € 4,882 ▲ € 15,828 vs 2023 (€ -10,945) Favourable step	€ 3,127,765 Profit after taxes 2025: € 3,127,765 ▲ € 3.1 million vs 2024 (€ 4,882) Favourable step	▲ € 3.1 million
Equity	€ 4,676,570 Equity 2022: € 4,676,570 First fiscal year in the series	€ 3,806,378 Equity 2023: € 3,806,378 ▼ 19% vs 2022 (€ 4,676,570) Unfavourable step	€ 3,811,261 Equity 2024: € 3,811,261 Unchanged (€ 3,806,378) Favourable step	€ 6,939,025 Equity 2025: € 6,939,025 ▲ 82% vs 2024 (€ 3,811,261) Favourable step	▲ 82%
Total debts	€ 6,294,657 Total debts 2022: € 6,294,657 First fiscal year in the series	€ 5,835,512 Total debts 2023: € 5,835,512 ▼ 7% vs 2022 (€ 6,294,657) Favourable step	€ 5,857,459 Total debts 2024: € 5,857,459 Unchanged (€ 5,835,512) Unfavourable step	€ 4,633,684 Total debts 2025: € 4,633,684 ▼ 21% vs 2024 (€ 5,857,459) Favourable step	▼ 21%
Cash	€ 1,207,611 Cash 2022: € 1,207,611 First fiscal year in the series	€ 157,151 Cash 2023: € 157,151 ▼ 87% vs 2022 (€ 1,207,611) Unfavourable step	€ 61,609 Cash 2024: € 61,609 ▼ 61% vs 2023 (€ 157,151) Unfavourable step	€ 543,138 Cash 2025: € 543,138 ▲ € 481,530 vs 2024 (€ 61,609) Favourable step	▲ € 481,530
Land & buildings	€ 2,484,972 Land & buildings 2022: € 2,484,972 First fiscal year in the series	€ 2,753,884 Land & buildings 2023: € 2,753,884 ▲ 11% vs 2022 (€ 2,484,972) Unchanged	€ 2,598,865 Land & buildings 2024: € 2,598,865 ▼ 6% vs 2023 (€ 2,753,884) Unchanged	€ 1,992,738 Land & buildings 2025: € 1,992,738 ▼ 23% vs 2024 (€ 2,598,865) Unchanged	▼ 23%
Retained profit	€ 3,237,799 Retained profit 2022: € 3,237,799 First fiscal year in the series	€ 2,367,607 Retained profit 2023: € 2,367,607 ▼ 27% vs 2022 (€ 3,237,799) Unfavourable step	€ 2,372,489 Retained profit 2024: € 2,372,489 Unchanged (€ 2,367,607) Favourable step	€ 5,500,254 Retained profit 2025: € 5,500,254 ▲ 132% vs 2024 (€ 2,372,489) Favourable step	▲ 132%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 859,246 Dividend 2023: € 859,246 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 859,246) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 3,457,296 Bank debt 2022: € 3,457,296 First fiscal year in the series	€ 3,752,528 Bank debt 2023: € 3,752,528 ▲ 9% vs 2022 (€ 3,457,296) Unfavourable step	€ 3,753,609 Bank debt 2024: € 3,753,609 Unchanged (€ 3,752,528) Unfavourable step	€ 2,691,514 Bank debt 2025: € 2,691,514 ▼ 28% vs 2024 (€ 3,753,609) Favourable step	▼ 28%
Balance sheet total	€ 11,158,434 Balance sheet total 2022: € 11,158,434 First fiscal year in the series	€ 9,816,775 Balance sheet total 2023: € 9,816,775 ▼ 12% vs 2022 (€ 11,158,434) Unchanged	€ 9,833,798 Balance sheet total 2024: € 9,833,798 Unchanged (€ 9,816,775) Unchanged	€ 12,074,140 Balance sheet total 2025: € 12,074,140 ▲ 23% vs 2024 (€ 9,833,798) Unchanged	▲ 23%
Employees (FTE)	9.2 Employees (FTE) 2022: 9.2 First fiscal year in the series	9.3 Employees (FTE) 2023: 9.3 ▲ 0.1 vs 2022 (9.2) Unchanged	8.4 Employees (FTE) 2024: 8.4 ▼ 0.9 vs 2023 (9.3) Unchanged	8.5 Employees (FTE) 2025: 8.5 ▲ 0.1 vs 2024 (8.4) Unchanged	▲ 0.1

Key figures of TREATEX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TREATEX?

What happened at TREATEX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 8, 2026 New annual accounts for financial year 2025: profit of € 3.1 million (▲ € 3.1 million vs 2024). Source: NBB ↗
2024 TODEX BV became a director. NBB
Nov 1, 2020 New establishment in Genk. KBO
Nov 1, 2020 New establishment in Genk. KBO
2018 Dennis De Maeyer became a director. NBB
Jun 15, 1989 Start of the company according to the CBE. KBO

In short

From € 1 million profit in 2022 to € 3.1 million profit in 2025.

Paid € 913,701 in corporate taxes since 2022.

Best year ever: 2025, with € 3.1 million profit.

On average € 586,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

TODEX 80%

The stake of TODEX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

TREATEX

Behind TREATEX are TODEX BV and Dennis De Maeyer. The shares are held by TODEX (80%).

Directors

According to the 2025 annual accounts

TODEX BV

Director · represented by De Maeyer Tom

since 2024

Dennis De Maeyer

Director

Also active at: Esplanada, BRETON, MONARCH, E & B CONSULTING, TODEX

since 2018

Shareholders

TODEX

80%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Vaartstraat 34

3600 Genk

2.310.365.893

Vaartstraat 32

3600 Genk

Active since 1 November 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

TODEX same network

€ 177,539 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0437.745.657

VAT number

BE 0437.745.657

Registered office

Vaartstraat 34, 3600 Genk

Names & denominations

TREATEX

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

15 June 1989

Peppol

Active · Active since 21 Oct 2026

Activities · NACE

Vervaardiging van kunststoffen in primaire vormen

Handelsbemiddeling in de groothandel in brandstoffen, ertsen, metalen en chemische producten

Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen

View on CBE Public ↗ Annual accounts (NBB) ↗

TREATEX

Financials

What happened to TREATEX?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions